Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Seward achieves ISO14001 certification for minimising environmental impact

Seward Ltd., manufacturer of the world leading range of original Stomacher paddle blenders and accessories used in sample preparation for microbiological analysis, has received certification for ISO14001.

19 Sep 2014

PCI acquires Biotec Services International

PCI is pleased to announce it has acquired Biotec Services International. Biotec is a leading provider of Clinical Trial Services and Temperature Controlled Pharmaceutical Services headquartered in Bridgend, Wales in the United Kingdom.

19 Sep 2014

Isis receives $4 million in milestone payment from Achaogen for initiation of plazomicin Phase 3 study

Isis Pharmaceuticals, Inc. announced that it has earned a $4 million milestone payment from Achaogen, Inc. associated with the initiation of a Phase 3 study of plazomicin in patients with serious multi-drug resistant (MDR), gram-negative bacterial infections.

17 Sep 2014

Twinlab Consolidation becomes wholly-owned subsidiary of Twinlab Consolidated Holdings

As announced on August 11, 2014, Twinlab Consolidation Corporation completed its first transaction with the acquisition of Twinlab Corporation. Today, TCC announces the successful completion of its merger into Twinlab Consolidated Holdings Inc., resulting in TCC becoming a wholly-owned subsidiary of TLCC.

17 Sep 2014

Fast release drug delivery capsule launched by Medimetrics

Medtech innovator Medimetrics continues its expansion into the global medical devices sector with official recognition of its full design and product development capabilities and the launch of a new, fast release, drug delivery capsule.

17 Sep 2014

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).

17 Sep 2014

VAPE Holdings adds new line of products to its HIVE brand

Vape Holdings, Inc. (the "Company"), a holding company focused on providing healthy, efficient, and sustainable vaporization products, is pleased to announce the newest line of products under the HIVE brand, HIVE GLASS, which is set to release on or before December 1, 2014.

16 Sep 2014

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.

16 Sep 2014

Pharmaceutical Manufacturing Technology Centre launched in Ireland

The Minister for Skills, Research and Innovation, Damien English TD, today (Friday 12th September 2014) launched the Pharmaceutical Manufacturing Technology Centre (PMTC).

16 Sep 2014

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.

16 Sep 2014

Simple point-of-care testing device provides more rapid diagnosis of anemia

A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease.

15 Sep 2014

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

15 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

The European Commission granted marketing authorisation for Eli Lilly and Company and Boehringer Ingelheim's insulin glargine product, indicated to treat diabetes in adults, adolescents and children aged 2 years and above.

10 Sep 2014

Kinex Pharmaceuticals acquires QuaDPharma

Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed.

9 Sep 2014

Miriam Hospital receives grant from NIH to prevent spread of sexually transmitted HIV in women

The Miriam Hospital is part of a research collaboration that has received a $20 million grant from the National Institutes of Health (NIH) to develop an intravaginal ring (IVR) that can deliver powerful antiretroviral (ARV) drugs to prevent the spread of sexually transmitted HIV in women.

9 Sep 2014

Three Clemson startup companies receive $25,000 in seed money from USAP

Clemson University Research Foundation (CURF) announced that three Clemson startup companies have each received $25,000 in seed money from the University Sponsored Application Program (USAP) offered by SC Launch.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

Porvair Sciences has published an informative 8-page brochure providing scientists with a background to Chromatin Immunoprecipitation (ChIP), an introduction to Chromatrap® ChIP assay technology and how Chromatrap® compares to traditional bead based methodologies.

From Chromatrap® - Porvair Sciences Ltd 4 Sep 2014

State highlights: Mass. health spending slows, but for how long?

Two years ago, Massachusetts set what was considered an ambitious goal: The state would not let that persistent monster, rising health care costs, increase faster than the economy as a whole.

4 Sep 2014

Manufacturing News and Research

Further Reading

Seward achieves ISO14001 certification for minimising environmental impact

PCI acquires Biotec Services International

Isis receives $4 million in milestone payment from Achaogen for initiation of plazomicin Phase 3 study

Twinlab Consolidation becomes wholly-owned subsidiary of Twinlab Consolidated Holdings

Fast release drug delivery capsule launched by Medimetrics

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

VAPE Holdings adds new line of products to its HIVE brand

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Pharmaceutical Manufacturing Technology Centre launched in Ireland

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Simple point-of-care testing device provides more rapid diagnosis of anemia

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

Kinex Pharmaceuticals acquires QuaDPharma

Miriam Hospital receives grant from NIH to prevent spread of sexually transmitted HIV in women

Three Clemson startup companies receive $25,000 in seed money from USAP

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

State highlights: Mass. health spending slows, but for how long?

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News